1. Market Research
  2. > Biotechnology
  3. > Genomics Proteomics and Enabling Technology Market Trends
Global Cancer Biomarkers Market Research and Analysis 2015-2022

Global Cancer Biomarkers Market Research and Analysis 2015-2022

  • March 2017
  • 120 pages
  • ID: 5336652
  • Format: PDF
  • By Orion Market Research

Summary

Table of Contents

Global Cancer biomarkers market is estimated to witness an exponential growth rate of 11.7% during 2017-2022. The growth of the market is backed by the increasing prevalence of cancer coupled with the rising awareness related to the usage of biomarkers at various stages of cancer.

According to WHO, Cancer is the leading cause of morbidity as well as mortality at global level with around 14 million new cases registered in 2012. Over the next two decades, the number of new cases of cases if projected to rise by about 70%. Lack of physical activities, improper diet, frequent sun & UV exposure and increasing consumption of tobacco are some of the key factors that have attributed towards the increasing prevalence of cancer.

Around 22% of cancer deaths are caused due to tobacco consumption and is regarded as the key risk factor for cancer. Along with it, few internal factors such as genetic mutation, hormonal imbalance and metabolic mutation also contributes towards the rise in cancer cases which in turn boosts the demand for cancer biomarkers.

Moreover, increasing demand for clinical diagnosis in cancer’s early stages and growing geriatric population base further propels the usage rates of cancer biomarkers. Increasing utilization of the biomarkers in surrogate endpoints & drug targets developments, rising interest among researchers & students regarding cancer diagnostic researchers and growing need for the biomarkers in cancer research are few critical success factors for the growth of the global cancer biomarkers market.

Technological advancements in the omics technology and rising demand for personalized medicine in therapies of cancer are projected to create growth opportunities for the global market which will attribute significantly towards the market value of the cancer biomarkers. However, poor reimbursement policies and high cost associated with cancer biomarkers are the key factors hampering the growth of the global market. Technical issues related to sample collection as well as storage further impede the growth of the global cancer biomarkers market.

Geographical Insights
Global Cancer biomarkers market can be segmented geographically into North America, Asia Pacific, Europe and RoW. In 2016, North America leads the global cancer biomarkers market followed by Europe and Asia Pacific.

The growth of the North American market is driven by the increasing government support for biomarkers discovery and development and growing usage of biomarkers in drug discovery & development by the pharmaceutical companies within the region.

Early adoption of the omics technology for the discovery of biomarkers and rising demand for personalized medicine have further propelled the growth of the cancer biomarkers market in North America. Furthermore, Asia Pacific is estimated to witness the highest growth rate owing to the favorable government funding for cancer biomarker research and increasing prevalence of cancer within the regional countries.

Rising focus of international players in emerging economies and growing demand for advanced healthcare facilities in developing countries such as China and India are the other key factors that have attributed extensively towards the growth of the cancer biomarkers market in Asia Pacific.

Growing awareness related to the benefits of biomarkers in treatment of cancer such as its ability to target the patient specific molecular structure to enhance the early stage of cancer detection & screening as well as to detect the cancer type is also expected to boost the growth of the Asia Pacific market in the upcoming scenario.

The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Competitive Insights
The key players of Cancer biomarkers market include Qiagen N.V., Agilent Technologies, Inc., Affymetrix, Inc., Roche Diagnostics Ltd., Illumina, Inc., Merck & Co. Inc., Becton, Dickinson and Company and Pfizer, Inc. The key players are constantly focusing on new product developments as well as upgrading their product portfolios to gain a competitive edge over other players.

Product launch, geographic expansion and mergers & acquisitions are some of the key strategies adopted by the market players in the past few years. On January 2017, Qiagen N.V. acquired OmicSoft Corporation that provides access to the OmicSoft’s powerful multi-omics data management infrastructure solution and complements Qiagen’s bioinformatics portfolio.

Market Segmentation:

• Cancer biomarkers Market by Biomarker Type
o Genetic Biomarkers
o Protein Biomarkers
o Other Cancer Biomarkers

• Cancer biomarkers Market by Tumor Type
o Lung Cancer
o Prostate Cancer
o Breast Cancer
o Colorectal Cancer
o Cervical Cancer
o Other Cancers

• Cancer biomarkers Market by Application
o Drug Discovery & Development
o Diagnosis
o Risk Assessment
o Prognosis
o Others

• Cancer biomarkers Market by Profiling Technologies
o Omics Technologies
- Proteomics
• 2 -D Gel Electrophoresis
• Mass Spectrometry
• Imaging Mass Spectrometry
• Maldi Mass Spectrometry
• Antibody Array Technology
• Peptide Array Technology
• Protein Microarray Technology
- Genomics
• Microarrays
• Next Generation Sequencing
• PCR
- Other Omics Technologies
o Immunoassays
- Immunohistochemistry
- ELISA
- Flow Cytometry
o Imaging Technologies
- Positron Emission Tomography
- Computed Tomography
- Magnetic Resonance Imaging
- Mammography
- Ultrasound
o Cytogenetics
- In situ Hybridization
- Others
- Bioinformatics

OMR report covers:
• Comprehensive research methodology of global Cancer biomarkers market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Cancer biomarkers market
• Insights about market determinants which are stimulating the global Cancer biomarkers market
• Detailed and extensive market segments with regional distribution of researched revenues
• Extensive profiles and recent developments of market players

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Predisposition Biomarkers: Technologies and Global Markets

Predisposition Biomarkers: Technologies and Global Markets

  • $ 3950
  • October 2019

Report Includes:- An overview of technologies and global markets for the predisposition biomarkers- Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound ...

Biomarkers: Discovery Techniques and Applications – A Global Market Overview

Biomarkers: Discovery Techniques and Applications – A Global Market Overview

  • $ 4860
  • August 2019

A more focused discovery process using proteins as biomarkers for various diseases has been in the development stage for quite some time now. The recent years have witnessed a more targeted approach in ...

Global Biomarkers Industry

Global Biomarkers Industry

  • $ 5450
  • October 2019

Biomarkers market worldwide is projected to grow by US$59 Billion, driven by a compounded growth of 14.1%. Safety, one of the segments analyzed and sized in this study, displays the potential to grow at ...

Biobanking Market $ 5100 July 2019


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on